JPMorgan Chase & Co’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24 | Sell |
15
-8,388
| -100% | -$13.4K | ﹤0.01% | 6057 |
|
|
2025
Q1 | $10.3K | Buy |
8,403
+914
| +12% | +$1.12K | ﹤0.01% | 5436 |
|
|
2024
Q4 | $14.2K | Buy |
7,489
+343
| +5% | +$648 | ﹤0.01% | 5281 |
|
|
2024
Q3 | $38.2K | Buy |
7,146
+3,595
| +101% | +$19.2K | ﹤0.01% | 5052 |
|
|
2024
Q2 | $26.2K | Sell |
3,551
-150
| -4% | -$1.11K | ﹤0.01% | 5090 |
|
|
2024
Q1 | $44.2K | Sell |
3,701
-1,338
| -27% | -$16K | ﹤0.01% | 5024 |
|
|
2023
Q4 | $39.7K | Hold |
5,039
| – | – | ﹤0.01% | 5073 |
|
|
2023
Q3 | $22.3K | Sell |
5,039
-987
| -16% | -$4.36K | ﹤0.01% | 5127 |
|
|
2023
Q2 | $210K | Buy |
6,026
+90
| +2% | +$3.13K | ﹤0.01% | 4249 |
|
|
2023
Q1 | $129K | Buy |
5,936
+2,571
| +76% | +$55.9K | ﹤0.01% | 4545 |
|
|
2022
Q4 | $72K | Buy |
3,365
+129
| +4% | +$2.76K | ﹤0.01% | 4609 |
|
|
2022
Q3 | $79K | Buy |
3,236
+67
| +2% | +$1.64K | ﹤0.01% | 4559 |
|
|
2022
Q2 | $65K | Buy |
3,169
+496
| +19% | +$10.2K | ﹤0.01% | 4776 |
|
|
2022
Q1 | $95K | Buy |
2,673
+949
| +55% | +$33.7K | ﹤0.01% | 4769 |
|
|
2021
Q4 | $47K | Sell |
1,724
-567
| -25% | -$15.5K | ﹤0.01% | 5097 |
|
|
2021
Q3 | $100K | Buy |
2,291
+610
| +36% | +$26.6K | ﹤0.01% | 4714 |
|
|
2021
Q2 | $84K | Buy |
+1,681
| New | +$84K | ﹤0.01% | 4820 |
|